Neurocognitive disorders Flashcards

1
Q

Neurocognitive disorders: A new category in dsm-5

A
  • Previously “organic mental disorders” and “cognitive disorders”
  • “Neurocognitive disorders” because of overlap between dementia and amnestic disorders
  • All disorders influenced by brain -> these disorders are categorized by this influence
  • Brain cell regeneration?
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Delirium:

A

often a temporary condition displayed as confusion and disorientation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Mild or major neurocognitive disorder:

A

a progressive condition marked by gradual deterioration of a range of cognitive abilities

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Delirium: diagnostic criteria

A
  • A. A disturbance in attention and awareness
  • B. The disturbance develops over a short period of time, represents a change from baseline attention and awareness, and tends to fluctuate in severity during the course of a day
  • C. An additional disturbance in cognition
  • D. Disturbances in Criteria A and C are not better explained by another preexisting, established, or evolving neurocognitive disorder and do not occur in the context of a severely reduced level of arousal, such as coma
  • E. There is evidence from the history, physical examination, or laboratory findings that the disturbance is a direct physiological consequence of another medical condition, substance intoxication, or withdrawal
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Delirium: demographics and aetiology

A
  • Prevalence: 20% of older adults admitted into acute care facilities/ hospitals
  • Course
    • Rapid onset
    • Symptoms may vary over course of day
    • Typically resides quickly
    • Effects may be more long-lasting
  • Aetiology
    • Improper use of medications, high fever (in children), dementia, sign of end of life (in ¼ of cases), sleep deprivation, alcohol withdrawal, immobility, excessive stress
    • Older people more likely to suffer delirium
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Delirium: treatment and prevention

A
  • Treatment will depend on identified cause
    • Substances or infection/injury
    • First line of treatment: psychosocial intervention
      • Provide reassurance to individual, give familiar personal belongings
    • Delirium brought on by withdrawal from alcohol or other drugs is usually treated with haloperidol or other antipsychotic medications
    • When case is unknown haloperidol or olanzapine are prescribed
  • Prevention
    • Proper medical care for illnesses and drug monitoring
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Neurocognitive disorders

A
  • Far more gradual decline in functioning
  • Major neurocognitive disorder (previously labelled dementia)
    • Gradual deterioration of brain functioning that affects memory, judgment, language, other advanced cognitive processes
  • Mild neurocognitive disorder
    • Early stages of cognitive decline
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Mild neurocognitive disorder: diagnostic criteria

A
  • A. Evidence of modest decline from a previous level of performance in one or more cognitive domains
    • Concern of the individual, a knowledgeable informant, or the clinician that there has been a mild decline in functioning, and
    • A modest impairment in cognitive performance, preferably documented by standardized neuropsychological testing or, in its absence, another quantified clinical assessment
  • B. Cognitive deficits do not interfere with capacity for independence in everyday activities
  • C. Cognitive deficits do not occur exclusively in the context of a delirium
  • D. Cognitive deficits are not better explained by another mental disorder
  • Specify whether due to:
    • Alzheimer’s disease, frontotemporal lobe degeneration, etc.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Major neurocognitive disorder: diagnostic criteria

A
  • A. Evidence of significant cognitive decline from a previous level of performance in one or more cognitive domains
    • Concern of the individual, a knowledgeable informant, or the clinician that there has been a significant decline in cognitive functioning
    • A substantial impairment in cognitive performance, preferably documented by standardized neuropsychological testing or, in its absence, another quantified clinical assessment
  • B. Cognitive deficits interfere with independence in everyday activities
  • C. The cognitive deficits do not occur exclusively in the context of a delirium
  • D. Cognitive deficits not better explained by another mental disorder
  • Specify whether due to:
    • Alzheimer’s disease, frontotemporal lobe degeneration, etc.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Neurocognitive disorder: clinical description

Causes

A
  • Will depend on which type person has
  • Initial stages: impairment in memory for recent events, long-term still relatively intact
  • Delusions can occur
  • Emotional changes: depression, agitation, aggression, apathy
  • Onset:
    • Can develop at any age, more frequently seen in older adults
  • Causes (classes of neurocognitive disorders based on aetiology in DSM 5)
    • Alzheimer’s disease
    • Vascular disease
    • Frontotemporal degeneration
    • Traumatic brain injury
    • Lewy body disease
    • Parkinson’s disease
    • HIV infection
    • Substance use
    • Huntington’s disease
    • Prion disease
    • Other medical condition
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Agnosia:

A

common symptom of neurocognitive disorders where there is an inability to recognise and name objects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Facial agnosia

A

the inability to recognise even familiar faces

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Neurocognitive disorder: Prevalence

A
  • Will depend on which type, but in general prevalence increases with increasing age
    • At age 65, 5%
    • At age 85, 20% - 40%
    • At age 100, 100%
  • Rate of new cases doubles every 5 years after age 75 (aging population)
  • More prevalent among women (due to Alzheimer’s disease)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Neurocognitive disorder due to Alzheimer’s disease: Diagnostic criteria

A
  • A. The criteria are met for major or mild neurocognitive disorder
  • B. There is insidious onset and gradual progression of impairment in one or more cognitive domains
  • C. Criteria are met for either probable or possible Alzheimer’s disease as follows:
    • Major: Probable Alzheimer’s disease diagnosed if either one of following is present
      • Evidence of a causative Alzheimer’s disease genetic mutation from family history or genetic testing
    • All three of following present:
      • Clear evidence of decline in memory and learning and at least one other cognitive domain
      • Steadily progressive, gradual decline in cognition, without extended plateaus
      • No evidence of mixed aetiology
    • Mild:
      • Probable diagnosis if evidence of causative Alzheimer’s disease genetic mutation
      • Possible diagnosis if no evidence of genetic mutation and all three present:
        • Clear evidence of decline in memory and learning
        • Steadily progressive, gradual decline in cognition, without extended plateaus
        • No evidence of mixed aetiology
  • D. Disturbance not better explained by cerebrovascular disease, another neurodegenerative disease, the effects of a substance, or another mental, neurological, or systemic disorder
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Neurocognitive disorder due to Alzheimer’s disease

Symptoms

Cognitive symptoms

Diagnosis

A
  • Symptoms
    • Multiple cognitive deficits that develop gradually
    • Predominant presentation: impairments of memory, orientation, judgment, reasoning
    • Later stages: agitation, confusion, depression, anxiety, aggression
  • Specific cognitive symptoms:
    • Aphasia (difficulty with language)
    • Apraxia (impaired motor functioning)
    • Agnosia (inability to recognise objects)
    • Difficulties with executive functioning tasks
  • Diagnosis
    • Used to be possible only post-mortem, but now looking at brain scans and spinal fluid assessments as possibilities
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Neurocognitive disorder due to Alzheimer’s disease: demographics and course

A
  • High prevalence in less educated persons
    • Cognitive reserve hypothesis
  • Higher prevalence in women
  • Roughly same prevalence across ethnic groups
  • Course:
    • Cognitive deterioration slow during early and later stages
    • Rapid during middle stages
    • Average survival time is 8 years from diagnosis
    • Onset typically in 60s or 70s, but can be earlier

  • Aprox. 50% of neurocognitive disorders are a result of Alzheimer’s*
  • Research confirms that that greater educational level may predict a delay in the observation of Alzheimer’s symptoms (suggests that education doesn’t prevent Alzheimer’s but creates buffer period of better functioning)*

Cognitive reserve hypothesis suggest that the more synapses a person develops throughout life, the more neuronal death must take place before the signs of dementia are obvious

17
Q

Major or Mild Vascular neurocognitive disorder: Diagnostic criteria

A
  • A. The criteria are met for major or mild neurocognitive disorder
  • B. The clinical features are consistent with a vascular aetiology as suggested by either of the following:
    • Onset of the cognitive deficits is temporally related to one or more cerebrovascular events
    • Evidence for decline is prominent in complex attention
  • C. There is evidence of the presence of cerebrovascular disease from history, physical examination, and/or neuroimaging considered sufficient to account for the neurocognitive deficits
  • D. Symptoms are not better explained by another brain disease or systemic disorder. Probable vascular neurocognitive disorder is diagnosed if one of the following is present (otherwise diagnose “possible”)
    • Clinical criteria are supported by neuroimaging evidence of significant parenchymal injury attributed to cerebrovascular disease (neuroimaging-supported)
    • Neurocognitive syndrome is temporally related to one or more documented cerebrovascular events
    • Both clinical and genetic evidence of cerebrovascular disease is present
18
Q

Cerebrovascular

A

relating to the brain and its blood vessels

19
Q

Vascular neurocognitive disorder

A
  • Blood vessels in brain are blocked/damaged
  • Lower incidence rates than Alzheimer’s disease
    • 70 – 75 years of age: 1.5%
    • Over 80: 15%
  • Aetiology
    • Stroke, cardiovascular disease
  • Higher prevalence in men
  • Symptoms will depend on site of damage in brain
    • Often includes decline in speed of information processing, executive functioning
  • Onset is typically more sudden than Alzheimer’s type, probably because the disorder is result of a stroke, which inflicts brain damage immediately
20
Q

Other Types of neurocognitive disorder

  • Alzheimer’s disease
  • Vascular disease
  • Frontotemporal degeneration
  • Traumatic brain injury
  • Lewy body disease
  • Parkinson’s disease
  • HIV infection
  • Substance use
  • Huntington’s disease
  • Prion disease
  • Other medical condition
A
  • Traumatic brain injury
    • Including chronic traumatic encephalopathy
  • Frontotemporal neurocognitive disorder
    • An overarching term to categorise a variety of brain disorders that damage the frontal or temporal regions of the brain- areas that affect personality, language and behaviour
  • Pick’s disease
    • Produces symptoms similar to that of Alzheimer’s disease
    • Early onset (40s and 50s) last 5-10 years
  • Lewy body disease
    • Microscopic deposits of protein that damage the brain cells over time
    • Gradual onset including motor impairment
  • Parkinson’s disease
    • Estimated that about 75% of people who survive more than 10 years with Parkinson’s disease develop neurocognitive disorder
    • Primarily motor symptoms, stooped posture, speech soft and monotone
  • HIV
  • Huntington’s disease
    • Genetic disorder that initially affects motor movements
    • Depression, anxiety, aphasia
  • Prion disease
    • Caused by “prions”, proteins that can reproduce themselves and cause damage to brain cells leading to neurocognitive decline
    • Can only be contracted through cannibalism or accidental inoculations from an infected person’s blood
    • No known treatment, always fatal
  • Creutzfeldt-Jakob disease
    • A type of prions disease
    • Associated with mad cow’s disease
  • Substance/medication induced
    • 7% of people dependent on alcohol meet the criteria for a neurocognitive disorder
    • prolonged drug use and poor diet
21
Q

Aetiology of neurocognitive disorder

Biological

Psychological and social

A
  • Biological
    • Alzheimer’s disease
      • Neurofibrillary tangles, amyloid plaques, and brain atrophy (examined after death)
        • Brain atrophy itself cannot be deterministic if Alzheimer’s because it happens to many brains of older people
      • Multiple genes seem to be involved
      • Exercise may help reduce likelihood of disease, but only for some people
    • Head trauma
    • Other causes: diabetes, high blood pressure, herpes
  • Psychological and social
    • Lifestyle issues associated with cardiovascular pathology
    • Lack of certain vitamins (B9 and B12)
    • Occupational hazards contributing to head injury
22
Q

Treatment of neurocognitive disorder

A
  • Treatment prospects not good
  • Brain cell regeneration?
  • Goals of treatment:
    • Try to prevent certain conditions that bring on neurocognitive disorder (substance abuse or strokes)
    • Try to delay onset of symptoms to provide better quality of life
    • Attempt to help affected individuals and caregivers to cope
    • Intervention MUST target caregivers as well as afflicted persons
      • High rates of depression and stress in this population
      • Higher rates of neurocognitive disorders in caregivers
23
Q

Biological treatments neurocognitive disorder

A
  • Treatments available for some known causes (known infectious diseases, nutritional deficiencies and depression) if caught early
  • Blood thinning meds to reduce blood clotting
  • No known treatment for neurocognitive disorder caused by stroke, Parkinson’s, or Huntington’s diseases
  • Alzheimer’s disease
    • Cholinesterase inhibitors (prevent breakdown of acetylcholine)
      • Can have modest impact, but only in short-term
    • Treat associated depression
    • Vaccination in future?
24
Q

Psychosocial treatments neurocognitive disorders

A
  • Target both individual and caregivers
  • Earlier stages
    • Teach skills to compensate for lost abilities
    • Cognitive stimulation
  • Later stages
    • Severe impairment and dysregulated behaviour
    • May not be able to engage in basic functions of living, may display inappropriate sexual and/or aggressive behaviour
    • Teach communication skills?
  • Caregivers should be taught how to deal with situation
  • Bottom line:
    • Best medications provide some recovery but do not prevent eventual decline
    • Psychological interventions may help people cope with loss of cognitive abilities
    • Provide psychological interventions to caregivers in early and late stages of decline
25
Q

Other

A
  • Overall, the outlook for slowing, but not stopping, the cognitive decline characterised by neurocognitive disorder is optimistic*
  • Managed care and patient counselling have been successful in preventing delirium in older adults*
  • Treatment for delirium depends on the cause of the episode and can include medications, psychosocial interventions or both*
  • Delirium severely affects people’s memory, making tasks such as recalling ones own name difficult*
  • The elderly population is at greatest risk of experiencing delirium resulting in improper use of medications*
  • Various types of brain trauma, such as head injury or infection, have been linked to delirium*
  • People who suffer from delirium appear to be confused or out of touch with their surroundings*
  • Timmy’s elderly grandmother does not recognise her home any more (agnosia)*
  • She can no longer form complete, coherent sentences (aphasia)*
  • She no longer recognises Timmy when he visits, even though he is her only grandchild (facial agnosia)*
  • Julian is a recovering alcoholic. When asked about his wild adventures as a young man, his stories usually end quickly because he can’t remember the whole tale. He even has to write down things he has to do in a notebook, otherwise, he’s likely to forget (substance-induced neurocognitive disorder)*
  • Mr. Brown has suffered from a number of strokes but can still care for himself. His ability to remember important things, however, has been declining steadily for the past few years (vascular neurocognitive disorder)*
  • A decline in cognitive functioning that is gradual and continuous and has been associated with neurofibrillary tangles and amyloid plaques (neurocognitive disorder due to Alzheimer’s disease)*